ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GTBP GT Biopharma Inc

2.80
-0.02 (-0.71%)
Last Updated: 15:57:45
Delayed by 15 minutes
Share Name Share Symbol Market Type
GT Biopharma Inc NASDAQ:GTBP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -0.71% 2.80 2.77 2.80 2.8699 2.70 2.80 16,583 15:57:45

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

06/11/2023 10:23pm

Edgar (US Regulatory)


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 14A

 

(Rule 14a-101)

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

 

Filed by the registrant ☒ Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement Confidential, For Use of the Commission Only
Definitive Proxy Statement   (as permitted by Rule 14a-6(e)(2))
Definitive Additional Materials    
Soliciting Material under Rule 14a-12    

 

GT BIOPHARMA, INC.

(Name of Registrant as Specified in Its Charter)

 

N/A

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No Fee Required
   
Fee paid previously with preliminary materials
   
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

 

 

 

 

 

 

 


1 Year GT Biopharma Chart

1 Year GT Biopharma Chart

1 Month GT Biopharma Chart

1 Month GT Biopharma Chart

Your Recent History

Delayed Upgrade Clock